The All-India Institute of Medical Sciences (AIIMS) in Bathinda has made a significant advancement in stem cell therapy, offering new hope for people with heart problems. Researchers at AIIMS Bathinda are testing the use of stem cells, which could one day provide an alternative to surgeries and transplants.
The team, led by Dr. Sanjay Kumar from the biochemistry department, has set up a special laboratory to isolate and grow stem cells from umbilical cords. Stem cells are known for their ability to grow into different types of cells, which makes them useful for treating various diseases, including heart conditions.
Heart disease is a major global issue, causing millions of deaths each year. The AIIMS researchers believe that stem cells could play a key role in repairing damaged heart tissues, potentially leading to faster recovery and fewer side effects compared to traditional treatments.
Dr. Akhilesh Pathak, the Dean of AIIMS Bathinda, highlighted that this is a groundbreaking achievement for the institute, which is now the second AIIMS in India to have a state-of-the-art stem cell therapy lab. However, the work is still in its early stages and needs approval from national health authorities before it can be used widely.
The research is funded by the Indian government’s Department of Science and Technology and is focused on standardizing the process for using stem cells in heart treatments. According to Dr. Kumar, it may take about a year for the technique to be fully validated and ready for wider use.
AIIMS Bathinda’s team is excited about the progress, but they acknowledge that stem cell therapy is a complex field. More research is needed before it becomes a common treatment for heart patients.
The institute is eagerly awaiting the next steps and hoping for positive results in the near future.
